amorphigenin has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, HB; Chin, YW; Cragg, GM; Kinghorn, AD; Mbwambo, ZH; Mdee, LK; Mi, Q; Swanson, SM | 1 |
| Bridges, HR; Hirst, J; Kidd, SL; Mateu, N; Osberger, TJ; Russell, DA; Serreli, R; Sore, HF; Spring, DR | 1 |
2 other study(ies) available for amorphigenin and Cancer of Prostate
| Article | Year |
|---|---|
Prenylated flavonoids from the root bark of Berchemia discolor, a Tanzanian medicinal plant.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Screening Assays, Antitumor; Flavonoids; Humans; Male; Molecular Structure; Plant Bark; Plant Roots; Plants, Medicinal; Prostatic Neoplasms; Rhamnaceae; Tanzania | 2006 |
Hydroxylated Rotenoids Selectively Inhibit the Proliferation of Prostate Cancer Cells.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Cattle; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Electron Transport Complex I; Humans; Male; Mitochondrial Membranes; Molecular Structure; Prostatic Neoplasms; Rotenone; Uncoupling Agents | 2020 |